Thalidomide Therapies For Renal Cell Cancer
Links shared publicly online about this topic
An Update On Targeted Therapy In Metastatic Renal Cell Carcinoma
medicalnewstoday.com — “UroToday.com - For many years the mainstay of treatment for metastatic renal cell carcinoma (RCC) was immunotherapy, with response rates of from 10% to 20%. An improved understanding of the molec” View full resource at medicalnewstoday.com
Most Recently Shared on August 2, 2010 at 7:37 pm By:
An Update On Targeted Therapy In Metastatic Renal Cell Carcinoma UroToday.com - For many years the mainstay of treatmen.. http://dld.bz/pSsc
[Renal cell carcinoma management and therapies in ... [Bull Cancer. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on May 21, 2010 at 9:11 am By:
ACOR Kidney Cancer Health Organization
[Renal cell carcinoma management and therapies in 2010] - http://bit.ly/cDwGqr
Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial -- Lee et al. 101 (15): 1049 -- JNCI Journal of the National Cancer Institute
jnci.oxfordjournals.org — “Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial -- Lee et al. 101 (15): 1049 -- JNCI Journal of the National Cancer Institute” View full resource at jnci.oxfordjournals.org
Most Recently Shared on July 17, 2009 at 2:59 pm By:
J Nat'l Cancer Inst Medical Journal and Oncology
Read the abstract for the JNCI study on thalidomide/lung cancer here: http://budurl.com/j7c3
Oncology Medical News about Renal cell carcinoma
mdlinx.com — “Spontaneous bilateral pneumothorax in metastatic renal cell carcinoma on sunitinib therapy” View full resource at mdlinx.com
Most Recently Shared on March 31, 2010 at 9:56 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Spontaneous bilateral pneumothorax in metastatic renal cell carcinoma on sunitinib therapy: Cancer Chemoth... http://bit.ly/cbGicE #HemeOnc
T-Cell Receptor Gene"Modified T Cells with Shared Renal Cell Carcinoma Specificity for Adoptive T-Cell Therapy " Clinical Cancer Research
clincancerres.aacrjournals.org — “T-Cell Receptor Gene"Modified T Cells with Shared Renal Cell Carcinoma Specificity for Adoptive T-Cell Therapy " Clinical Cancer Research” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on April 27, 2010 at 4:07 pm By:
Kidney Cancer Health Executive
T-Cell Receptor Gene–Modified T Cells with Shared Renal Cell Carcinoma Specificity for Adoptive T-Cell Therapy http://bit.ly/a1q9Ls
Preview Page - http://www.allkidney.com/2009/09/kidney-cancer-treatment-medical-therapy-of-renal-cell-cancer.html
cli.gs — “Preview Page - http://www.allkidney.com/2009/09/kidney-cancer-treatment-medical-therapy-of-renal-cell-cancer.html” View full resource at cli.gs
Most Recently Shared on November 22, 2009 at 8:39 pm By:
Roger Smith Doctor, Internist, Nephrologist, and Physician
medical therapy of Kidney Cancer http://cli.gs/4G4uW
NICE Recommends Votrient® (Pazopanib) For The First-Line Treatment Of Advanced Renal Cell Carcinoma (RCC)
medicalnewstoday.com — “Patients in England and Wales living with advanced kidney cancer (renal cell carcinoma - RCC) are one step closer to being able to access Votrient® (pazopanib), a targeted oral treatment, on” View full resource at medicalnewstoday.com
Most Recently Shared on January 3, 2011 at 11:22 am By:
MNT Drug Approvals Health News
NICE Recommends Votrient® (Pazopanib) For The First-Line Treatment Of Advanced Renal Cell Carcinoma (RCC) http://mnt.to/3Pwb #regulatory
Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial : The Lancet Oncology
thelancet.com — “Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial. By - Prof Sylvie Négrier MD, Gwe...” View full resource at thelancet.com
Most Recently Shared on June 11, 2011 at 1:05 pm By:
combination therapy for renal cancer hurdles http://t.co/AUyycoE
Access : Allogeneic gene-modified tumor cells (RCC-26|[sol]|IL-7|[sol]|CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study : Gene Therapy
nature.com — “At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.” View full resource at nature.com
Most Recently Shared on April 7, 2011 at 2:07 pm By:
Kidney Cancer Health Executive
Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell canc... http://bit.ly/dS1Xoe
Management of a New Isolated Metastasis during Sunitinib Treatment in Renal Cell Carcinoma Patients: A Lesson from Two Cases
content.karger.com — “Metastatic renal cell carcinoma (mRCC) is a difficult to treat malignancy and currently Sunitinib is a standard of care first-line therapy. A new metastasis during the treatment is considered a sign of drug failure and alternative therapeutic methods should be tried. Here, we report 2 cases of newly diagnosed isolated metastasis during Sunitinib treatment of mRCC patients. Our management plan included local palliative therapy to the lesion followed by recommencing of Sunitinib. This resulted in ” View full resource at content.karger.com
Most Recently Shared on December 2, 2010 at 8:55 am By:
Urology & Nephrology OW Health
Management of a New Isolated Metastasis during Sunitinib Treatment in Renal Cell Carcinoma Patients: A Lesson fr... http://bit.ly/eTc4Sc
Novel Therapy for Metastatic Kidney Cancer Developed at VCU Massey Cancer Center
newswise.com — “Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus.” View full resource at newswise.com
Most Recently Shared on December 15, 2010 at 2:03 pm By:
newswise Health Communicator and Health News
Novel Therapy for Metastatic Kidney Cancer Developed at VCU Massey Cancer Center: Researchers at Virginia Common... http://bit.ly/ewe9Qo
Novel Therapy for Metastatic Kidney Cancer Developed at VCU Massey Cancer Center
newswise.com — “Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus.” View full resource at newswise.com
Most Recently Shared on December 15, 2010 at 8:21 pm By:
The Kidney Group Physician Group and Nephrology
New treatment for #kidney #cancer reviewed in Cancer Biology and Therapy. http://bit.ly/i6c3dH
Cancer-seeking 'smart bombs' target kidney cancer cells
medicalxpress.com — “Researchers are halting kidney cancer with a novel form of radioimmunotherapy that zeroes in on antigens associated with renal cell carcinoma. Patients with progressive kidney cancer receiving up to three doses of the therapy show dramatic slowing of cancer growth and stabilization of their disease.” View full resource at medicalxpress.com
Most Recently Shared on June 6, 2011 at 5:40 pm By:
Cancer-seeking 'smart bombs' target kidney cancer cells http://bit.ly/kuynUu
Patients With Advanced Kidney Cancer: Switching To Metronomic Therapy Could Offer New Treatment Option
medicalnewstoday.com — “An article published Online First in The Lancet Oncology reports that a new multi-targeted chemo-switch drug regimen shows promising anti-tumour activity with manageable side effects in p” View full resource at medicalnewstoday.com
Most Recently Shared on February 16, 2010 at 1:08 pm By:
Patients With Advanced Kidney Cancer: Switching To Metronomic Therapy Could Offer New Treatment Option http://mnt.to/3xFR #healthnews
Drug Slows Advanced Kidney Cancer - Cancer Information (Cancers, Symptoms, Treatment) on MedicineNet.com
medicinenet.com — “Information on many different cancers includes symptoms, cancer detection and prevention, and treatment options.” View full resource at medicinenet.com
Most Recently Shared on January 27, 2010 at 7:04 pm By:
New Drug Slows Advanced Kidney Cancer Title: New Drug Slows Advanced Kidney CancerCategory: Health NewsCreated: 1/26/.. http://bit.ly/93mSGI
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
medical_tweets
-
ACOR Kidney Cancer
ACOR Kidney Cancer Medline Updates
-
J Nat'l Cancer Inst
JNCI, an Oxford University Press journal, publishes peer-reviewed original research and is an internationally acclaimed source for cancer news and information.
Advertisement
